That is necessary, due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be effective. Simply put, we need to know how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (second wave). And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're created to do. This was a development nearly nobody noticed. But it's going to have extensive implications for treating disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be plenty of investment opportunities in this area, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (exponential growth). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly significantly prior to going higher - the legacy report predictions. I've been covering bitcoin for a long time now. One of the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mostly educating readers. However that's not the huge concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff brown investment prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of fantastic private companies on the verge of hitting the public markets And I have actually been dealing with a brand-new method for you to invest even prior to these business go public.
This chance has been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the details. Go right here to book your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers know that tech isn't our typical beat (jeff brown biotech stock). And when it pertains to tech investing, we leave it to the professionals. The good news is, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing specialists we understand (genetic sequencing companies jeff brown). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing exponential growth and creating unbelievable opportunities for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. artificial intelligence. However despite what lots of readers might believe, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (diplomatic relations). Losing two months of manufacturing and sales truly impacts how many 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million units is remarkable. More significantly, the hold-ups triggered by the pandemic produced a load of suppressed need. And that demand is now going to be pushed into 2021. In fact, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown top biotech 2020. And that's not my only 5G prediction When I've discussed 5G in the past, I've explained its 3 different phases.
In Phase Two, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Phase Three, 5G services begin to be used (jeff brown 2020 predictions). That's when we begin to see applications operating on 5G networks. Believe of things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Phase Three by this summer. This begins something of a virtuous cycle: Many people don't truly appreciate the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open a suite of incredible applications: self-driving automobiles, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The investment opportunities moving forward will be enormous. Stepping far from 5G, the next essential innovation I predict in 2021 is CRISPR genetic editing. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR utilizes a similar concept but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For many years, CRISPR was primarily a niche technology that wasn't well comprehended. And during that time, there were truly only three business operating in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering incredible returns. This whole industry is effectively a greenfield chance.
There's room for lots of business to exist in this area. jeff brown biotech picks. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or three more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software application can precisely predict the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That is essential because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has been a trial-and-error process. Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but a number of drug therapies produced using this technology. This was one of those developments that practically nobody discovered. But it's going to have profound ramifications for treating illness. And, naturally, there will be plenty of investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe considerably before going greater. I've been covering bitcoin for a long period of time now. Among the very first research study reports I ever released was on bitcoin - jeff brown predictions for 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. black sea. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date since February 2021, however we could not individually verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to pick winning technology stocks. He spent more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent point of view on the market. He's constantly on the hunt for brand-new opportunities, and he shares a lot of his best picks in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully forecasted a few of the greatest financial occasions of the previous 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal each time, but Jeff Brown's precise predictions have earned him legions of devoted followers. That states a lot about his ability. The Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research uses a number of research study services with a large range of specializations - social media.
The business is also associated with Bonner & Partners, another well-respected research study publisher - biotech stocks jeff brown. On its website, Brownstone says its mission is to supply retail investors with professional-grade research study: "For too long, the very best financial investment research has actually not been offered to private investors. It has actually been usually booked for investment banks, hedge funds, private equity, and high-net-worth clients. last week. The objective of Brownstone Research study is to make that type of proprietary research study readily available to any financiers looking to gain an edge in the marketplaces. The objective is simple to provide distinct and rewarding investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you know even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. jeff brown stock market prediction. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown believes S.A.V. white house. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be weding two cutting-edge technologies: synthetic intelligence and electric vehicles. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing except the automotive industry's Holy Grail. As you know, electric automobiles and self-driving car stocks have actually been huge this year, but the Wall Street device has been huge on buzz without much tangible result. Despite a drastic increase in competition over the previous couple of years, Brown still believes Musk has the very best possibility of putting all of it together.
tech could be the magic string that ties it all together. S.A.V. represents Shared Autonomous Car, and it could be the future of transportation. Basically, this innovation would permit you to rent out your car as a self-governing, self-driving taxi when you're not utilizing it. You just leave the car and press a button on an app that informs the car to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a large piece of the revenues. It sounds insane, but it might be closed than you think.